Oragenics, Inc. (NYSEAMERICAN:OGEN – Get Free Report)’s share price shot up 3.5% during mid-day trading on Thursday. The company traded as high as $0.5030 and last traded at $0.5030. Approximately 17,416 shares changed hands during trading, a decline of 46% from the average session volume of 32,049 shares. The stock had previously closed at $0.4860.
Oragenics Stock Down 3.0%
The stock’s 50-day moving average price is $0.52 and its 200 day moving average price is $0.59. The firm has a market capitalization of $2.20 million, a price-to-earnings ratio of -0.02 and a beta of 1.25.
Oragenics (NYSEAMERICAN:OGEN – Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.57) earnings per share for the quarter.
Oragenics Company Profile
Oragenics, Inc is a biotechnology company focused on developing intranasal medicines for diseases and conditions affecting the central nervous system. Its platform is designed to use the nasal cavity as a route for delivering therapeutic compounds to the brain, with the goal of improving treatment access and reducing barriers associated with conventional drug delivery.
The company’s lead development program is ONP-002, an intranasal drug candidate being studied for the treatment of traumatic brain injury, including concussion.
Further Reading
- Five stocks we like better than Oragenics
- These 3 Overlooked Stocks Have Big Money Behind Them
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
- Best Buy Is Turning Amazon Fire TV Into a New Advertising Opportunity
- MarketBeat Week in Review – 09/21 – 09/25
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.
